lobbying_activities: 2819796

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2819796	9af5225f-3314-47dc-8f4b-6e5edb9d6c74	Q2	MARSHALL & POPP, LLC	401105121	BUTTERFLY NETWORK, INC.	2022	second_quarter	SCI	Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act. Issues related to FDA regulation of medical devices, including S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2022-07-15T00:38:34-04:00